Inhibition of LAK Cell Generation by Tumor Cell Supernatants
Author Information
Author(s): P.J. Guillou, C.W. Ramsden, S.S. Somers, P.C. Sedman
Primary Institution: University Department of Surgery, St James's University Hospital
Hypothesis
The study aims to determine whether tumor-derived soluble suppressor factors inhibit the generation of lymphokine-activated killer (LAK) cells.
Conclusion
Tumor cell supernatants can inhibit the generation of LAK cells in a dose and time-related manner.
Supporting Evidence
- Supernatants from certain tumor cell lines inhibited LAK cell generation.
- Inhibition was dose-dependent, with significant effects observed at concentrations as low as 5%.
- Heating the supernatants at 44 and 56°C did not eliminate their suppressive effects.
- LAK cell generation was significantly inhibited when supernatants were added within the first 48 hours of culture.
Takeaway
Some cancer cells can stop the immune system from making special cells that fight tumors, which might explain why some cancer treatments don't work.
Methodology
Peripheral blood mononuclear cells were isolated and cultured with tumor cell supernatants to assess the generation of LAK cells.
Limitations
The study primarily focuses on in vitro conditions, which may not fully replicate in vivo responses.
Participant Demographics
Healthy donors provided blood samples for the study.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website